img

Global Primary Hyperoxaluria Drug Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Primary Hyperoxaluria Drug Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Primary Hyperoxaluria Drug Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Primary Hyperoxaluria Drug industry at home and abroad, estimate the overall market scale of the Primary Hyperoxaluria Drug industry and the market share of major countries, Primary Hyperoxaluria Drug industry, and study and judge the downstream market demand of Primary Hyperoxaluria Drug through systematic research, Analyze the competition pattern of Primary Hyperoxaluria Drug, so as to help solve the pain points of various stakeholders in Primary Hyperoxaluria Drug industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Primary Hyperoxaluria Drug Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Primary Hyperoxaluria Drug Market?
Allena Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Intellia Therapeutics Inc
OxThera AB
Major Type of Primary Hyperoxaluria Drug Covered in XYZResearch report
ALLN-230
DCR-PHXC
ALN-GO1
Others
Application Segments Covered in XYZResearch Market
Hospital
Clinic
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Primary Hyperoxaluria Drug Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Primary Hyperoxaluria Drug Market by Value
2.2.1 Global Primary Hyperoxaluria Drug Revenue by Type
2.2.2 Global Primary Hyperoxaluria Drug Market by Value (%)
2.3 Global Primary Hyperoxaluria Drug Market by Production
2.3.1 Global Primary Hyperoxaluria Drug Production by Type
2.3.2 Global Primary Hyperoxaluria Drug Market by Production (%)

3. The Major Driver of Primary Hyperoxaluria Drug Industry
3.1 Historical & Forecast Global Primary Hyperoxaluria Drug Demand
3.2 Largest Application for Primary Hyperoxaluria Drug (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Primary Hyperoxaluria Drug Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Primary Hyperoxaluria Drug Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Primary Hyperoxaluria Drug Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Primary Hyperoxaluria Drug Average Price Trend
12.1 Market Price for Each Type of Primary Hyperoxaluria Drug in US (2018-2022)
12.2 Market Price for Each Type of Primary Hyperoxaluria Drug in Europe (2018-2022)
12.3 Market Price for Each Type of Primary Hyperoxaluria Drug in China (2018-2022)
12.4 Market Price for Each Type of Primary Hyperoxaluria Drug in Japan (2018-2022)
12.5 Market Price for Each Type of Primary Hyperoxaluria Drug in India (2018-2022)
12.6 Market Price for Each Type of Primary Hyperoxaluria Drug in Korea (2018-2022)
12.7 Market Price for Each Type of Primary Hyperoxaluria Drug in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Primary Hyperoxaluria Drug Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Primary Hyperoxaluria Drug

14. Primary Hyperoxaluria Drug Competitive Landscape
14.1 Allena Pharmaceuticals Inc
14.1.1 Allena Pharmaceuticals Inc Company Profiles
14.1.2 Allena Pharmaceuticals Inc Product Introduction
14.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Alnylam Pharmaceuticals Inc
14.2.1 Alnylam Pharmaceuticals Inc Company Profiles
14.2.2 Alnylam Pharmaceuticals Inc Product Introduction
14.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Dicerna Pharmaceuticals Inc
14.3.1 Dicerna Pharmaceuticals Inc Company Profiles
14.3.2 Dicerna Pharmaceuticals Inc Product Introduction
14.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Intellia Therapeutics Inc
14.4.1 Intellia Therapeutics Inc Company Profiles
14.4.2 Intellia Therapeutics Inc Product Introduction
14.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 OxThera AB
14.5.1 OxThera AB Company Profiles
14.5.2 OxThera AB Product Introduction
14.5.3 OxThera AB Primary Hyperoxaluria Drug Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Primary Hyperoxaluria Drug Industry (Volume)
Figure 2. Primary Hyperoxaluria Drug Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Primary Hyperoxaluria Drug Revenue in 2022
Figure 5. US Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Primary Hyperoxaluria Drug Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Primary Hyperoxaluria Drug Revenue, by Type (Million USD) (2018-2028)
Table 4. Primary Hyperoxaluria Drug Production, by Type (K Unit) (2018-2028)
Table 5. Primary Hyperoxaluria Drug Demand (K Unit) by Application (2018-2028)
Table 6. Primary Hyperoxaluria Drug Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Primary Hyperoxaluria Drug Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Primary Hyperoxaluria Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Primary Hyperoxaluria Drug in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Allena Pharmaceuticals Inc Profiles
Table 61. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Introduction
Table 62. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Allena Pharmaceuticals Inc Strategic initiatives
Table 64. Alnylam Pharmaceuticals Inc Profiles
Table 65. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Introduction
Table 66. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Alnylam Pharmaceuticals Inc Strategic initiatives
Table 68. Dicerna Pharmaceuticals Inc Profiles
Table 69. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Introduction
Table 70. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Dicerna Pharmaceuticals Inc Strategic initiatives
Table 72. Intellia Therapeutics Inc Profiles
Table 73. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Introduction
Table 74. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Intellia Therapeutics Inc Strategic initiatives
Table 76. OxThera AB Profiles
Table 77. OxThera AB Primary Hyperoxaluria Drug Product Introduction
Table 78. OxThera AB Primary Hyperoxaluria Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. OxThera AB Strategic initiatives